Skip to main content

FDA recall, , Moderate risk

Department of Defense - Army Blood Components

Department of Defense - Army Blood Components, for which arm preparation may have been performed incorrectly, were distributed.

Recall ended Sep 28, 2026. Still check yours.

What happened

The Department of Defense - Army recalled Whole Blood, Red Blood Cells, Leukocytes Reduced, Liquid Plasma, Red Blood Cells, and Fresh Frozen Plasma, for which arm preparation may have been performed incorrectly, were distributed. The recall began March 24, 2026, and was added to the FDA's Enforcement Report on September 28, 2026, with distribution in Texas, Armed Forces - Europe/Africa/Canada, and Armed Forces - Pacific.

3 photos

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:

  1. Check the FDA or company notice for instructions specific to this product.
  2. Ask your pharmacist or doctor whether your lot is affected and what to do.

Is yours affected?

5 products

Compare these details with yours, then check the recall notice to see which units are recalled.

  1. Whole Blood

    Reason: Whole Blood, for which arm preparation may have been performed incorrectly, were distributed.

  2. Red Blood Cells, Leukocytes Reduced

    Reason: Red Blood Cells, Leukocytes Reduced, for which arm preparation may have been performed incorrectly, were distributed.

  3. Liquid Plasma

    Reason: Liquid Plasma, for which arm preparation may have been performed incorrectly, were distributed.

  4. Red Blood Cells

    Reason: Red Blood Cells, for which arm preparation may have been performed incorrectly, were distributed.

  5. Fresh Frozen Plasma

    Reason: Fresh Frozen Plasma, for which arm preparation may have been performed incorrectly, were distributed.

Recall details

Company began the recall
Sold in

Armed Forces - Europe/Africa/Canada; Texas; Armed Forces - Pacific

Company
Department of Defense - Army
Risk

Moderate risk

Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99723
Recall numbers
B-0276-2026 to B-0280-2026

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA · Recall ended

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

Summary by Recall Canary, written with AI · summary updated Oct 12, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)